Andrew Ondo, MD
Dermatology · Las Cruces, NMNPI 1275536559
Payments from drug & device makers
What this record shows
This record is dominated by royalties or licence payments: $214,833 of the $215,269 with a category attached, or 99.8%. Aclaris Therapeutics, Inc. accounts for 99.8% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2019 at $215,011 and has fallen 99.9% since, to $135 in 2024. Among dermatology clinicians in NM with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 10 payments — averaging $21,527 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Aclaris Therapeutics, Inc.$215K
- Bristol Myers Squibb$91
- Novartis$90
- Janssen Scientific Affairs, LLC$87
- Incyte Corporation$60
- Verrica Pharmaceuticals Inc.$51
- plus $57 from 2 others
What the payments were for
- Royalty or licence$214,833100%
- Food & beverage$4360%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Aclaris Therapeutics, Inc. | 3 | $214,833 |
| Bristol Myers Squibb | 1 | $91 |
| Novartis | 1 | $90 |
| Janssen Scientific Affairs, LLC | 1 | $87 |
| Incyte Corporation | 1 | $60 |
| Verrica Pharmaceuticals Inc. | 1 | $51 |
| Sun Pharmaceutical Industries Inc. | 1 | $33 |
| E.r. Squibb & Sons, L.L.C. | 1 | $24 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Rhofade$214,833
How this compares
$215,269 in reported general payments places this provider in the 95th percentile of 52 dermatology providers in New Mexico.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cosentyx Sensoready (2 Pens)Secukinumab | 13 | $93,388 |
| Clobetasol Propionate | 130 | $7,526 |
| Acitretin | 19 | $5,496 |
| Fluorouracil | 45 | $3,123 |
| Dutasteride | 97 | $3,061 |
| Calcipotriene | 21 | $2,974 |
| Imiquimod | 218 | $2,566 |
| Tacrolimus | 25 | $2,354 |
| Doxycycline Hyclate | 57 | $2,132 |
| Ammonium Lactate | 81 | $2,026 |
| Metronidazole | 33 | $1,708 |
| Lidocaine | 80 | $1,617 |
| Ketoconazole | 108 | $1,604 |
| ValacyclovirValacyclovir Hcl | 80 | $1,459 |
| Mometasone Furoate | 31 | $889 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Las Cruces
- James KernerLas Cruces$4K
- Tiffany AutryLas Cruces$4K
- Richard HempsteadLas Cruces$86
- John DurkinAlbuquerque$153K
- Barbara EinhornAlbuquerque$15K
- Carol PurcellAlbuquerque$9K
- Michaela JacobsAlbuquerque$7K
- Deeptej SinghAlbuquerque$5K
- Darren KemptonAlbuquerque$4K
- Catherine Tchanque-FossuoAlbuquerque$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.